XML 53 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation - Additional Information (Detail)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Apr. 10, 2015
shares
Oct. 30, 2013
shares
Mar. 31, 2018
USD ($)
plan
$ / shares
shares
Dec. 31, 2017
shares
Dec. 07, 2016
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Additional awards granted (in shares)     793,236    
Weighted-average exercise price (in dollars per share) | $ / shares     $ 19.61    
Options outstanding, weighted average remaining contractual life (in years)     7 years 2 months 5 days    
Aggregate intrinsic value | $     $ 207,230    
Options exercisable, Weighted average remaining contractual life     6 years 1 month 4 days    
2005 Aerie Pharmaceutical Stock Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of equity compensation plans | plan     3    
Additional awards granted (in shares)   0      
2013 Omnibus incentive plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Additional awards granted (in shares) 0        
Equity awards (up to) (in shares)     5,729,068    
Inducement Award Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Equity awards (up to) (in shares)       874,500 418,000
Employee Stock Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation expense not yet recognized, options | $     $ 77,800    
Options, weighted average remaining recognition period (in years)     3 years 2 months 1 day    
Restricted stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation expense, other than options | $     $ 23,100    
Other than options, weighted average remaining recognition period (in years)     3 years 3 months 28 days    
Granted (in shares)     242,201    
Restricted stock | Minimum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based awards, vesting period (in years)     1 year    
Restricted stock | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based awards, vesting period (in years)     4 years    
Restricted Stock With Non-Market Performance Conditions          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Granted (in shares)       98,817  
Stock Appreciation Rights (SARs)          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Granted (in shares)     53,000    
Weighted-average exercise price (in dollars per share) | $ / shares     $ 55.15    
Options exercisable, Weighted average remaining contractual life     4 years 11 months 11 days